A drug that could save the sight of thousands of people is to be made available on the NHS in England.
Lucentis treats age-related macular degeneration (AMD), but previously Nice recommended that patients could not get the drug until they were blind in one eye.
Branwen Jeffreys reports.
Bookmark with:
What are these?
E-mail this to a friend